Physician profile
Maria E Rodriguez
NPI 1023132578
$1,481.90
in general payments reported to CMS, 2019-2025
24 companies · $38.59 in 2025
The $38.59 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.87 · 2020: $441 · 2021: $464 · 2022: $182 · 2023: $100 · 2024: $169 · 2025: $38.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.53 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $232.24 | 2021-2025 | Ozempic, Wegovy |
| Amarin Pharma, INC. | $199.17 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $190.26 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $111.71 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $83.84 | 2019-2022 | |
| Glaxosmithkline, LLC. | $77.05 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.96 | 2021-2022 | |
| Astellas Pharma US INC | $61.00 | 2023 | |
| Exact Sciences Corporation | $51.70 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.79 | 2020-2022 | |
| Daiichi Sankyo INC. | $43.17 | 2021 | |
| Allergan, INC. | $34.59 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.09 | 2021 | |
| Pfizer INC. | $30.57 | 2020 | |
| Scilex Pharmaceuticals INC. | $29.76 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.71 | 2020 | |
| Abbvie INC. | $27.77 | 2021-2022 | |
| Tris Pharma INC | $21.35 | 2020 | |
| Esperion Therapeutics, INC. | $20.45 | 2021 | |
| Banner Life Sciences, LLC | $19.83 | 2021 | |
| Axonics, INC. | $17.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.59 | 2022 | |
| Abbott Laboratories | $16.94 | 2021 | |
| Amgen INC. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.